This paper evaluates the role of tailored B-cell monitoring strategies in podocytopathies, advocating for a shift in clinical practice regarding how B-cell populations are tracked in these conditions.
Clinicians managing podocytopathies should consider individualized B-cell monitoring protocols rather than a one-size-fits-all approach, as emerging evidence suggests this may improve therapeutic decision-making.
Explore related topics